Purpose: The aim of this study was to compare surgical treatment options for young patients with glenohumeral arthritis. Methods: A systematic review of the English-language literature was conducted by searching PubMed, EMBASE, and Scopus with the following term: "(shoulder OR glenohumeral) AND (arthritis OR osteoarthritis) AND (young OR younger)." Studies that reported clinical or radiological outcomes of nonbiologic surgical treatment of generalized glenohumeral arthritis in patients younger than 60 years of age were included. Data were extracted to include study and patient characteristics, surgical technique, outcome scores, pain relief, satisfaction, functional improvement, return to activity, health-related quality of life, complications, need for and time to revision, range of motion, and radiological outcomes. Study quality was assessed with the Modified Coleman Methodology Score. Results: Thirty-two studies containing a total of 1,229 shoulders met the inclusion criteria and were included in the review. Pain scores improved significantly more after total shoulder arthroplasty (TSA) than after hemiarthroplasty (HA) (P < .001). Patient satisfaction was similar after HA and TSA. Revision surgery was equally likely after HA, TSA, and arthroscopic debridement (AD). Complications were significantly less common after AD than after HA (P ¼ .0049) and TSA (P < .001). AD and TSA afforded better recovery of active forward flexion and external rotation than did HA. At radiological follow-up, subluxation was similarly common after HA and TSA. Conclusions: According to current Level IV data, TSA provides greater improvement of pain and range of motion than does HA in the surgical treatment of young patients with glenohumeral arthritis. AD is an efficacious and particularly safe alternative in the short term for young patients with concerns about arthroplasty. Level of Evidence: Level IV, systematic review of Level IV studies.
D egenerative disease of the glenohumeral joint can cause significant pain and disability. Although surgical treatment with prosthetic replacement has been used with excellent success in the elderly, management in younger patients, especially those with high physical demands, remains controversial. 1, 2 The initial management of these patients consists of physical therapy, injections, activity modification, or a combination. 3, 4 Surgery is indicated when these conservative measures fail to sufficiently alleviate symptoms.
Surgical decision making involves consideration of various nonprosthetic and prosthetic treatments. 2 Although total shoulder arthroplasty (TSA) reliably ameliorates symptoms and improves shoulder function, [5] [6] [7] [8] [9] this treatment option may lead to component wear, component loosening, and the need for multiple revisions in young patients. 2, 10 Although hemiarthroplasty (HA) may be more attractive to young patients, this technique provides significantly less pain relief and functional improvement than does TSA. 9, 11 HA with biologic glenoid resurfacing (HA þ BR) was introduced as an alternative to TSA in younger active patients with glenohumeral arthritis. 12 A number of tissue sources have been used to resurface the glenoid in conjunction with HA, including fascia lata autograft, 13 anterior capsule, 13 lateral meniscus allograft, 14 and Achilles tendon allograft. 10 HA with concentric glenoid reaming, also known as ream and run (R & R), 15 avoids potential concerns about the durability of soft tissue interposition. 16 Arthroscopic debridement (AD) represents a joint-preserving approach that also effectively addresses symptom-producing pathologic conditions aside from the degenerative disease, including loose bodies, biceps tenosynovitis, and disease of the glenoid labrum or rotator cuff, or both. 17 This strategy can be supplemented with one or more arthroscopic procedures, including chondroplasty, capsular release, subacromial decompression, and biceps tenotomy or tenodesis. 17 The objective of this review was to compare clinical and radiological outcomes across nonbiologic surgical treatment options for glenohumeral arthritis in patients younger than 60 years. It was hypothesized that TSA and AD would provide outcomes superior to other available techniques.
Methods

Eligibility Criteria
The systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Therapeutic studies in human patients were included if they reported outcomes after surgical management of generalized arthritis of the glenohumeral joint in a patient sample with a mean age less than 60 years. Studies that addressed focal chondral defects or other pathologic conditions were excluded. No restrictions were imposed on the publication date, study design, level of evidence, or follow-up interval. Exclusion criteria included case reports or series with a sample size less than 5, laboratory studies, review or technique articles without outcome data, inclusion of heterogeneous procedures without segregation of outcome data, and analysis of the same cohort of patients across multiple studies.
Literature Search
Two independent reviewers (E.T.S., R.M.) searched PubMed, EMBASE, and Scopus to identify relevant English-language studies. The search term was as follows: "(shoulder OR glenohumeral) AND (arthritis OR osteoarthritis) AND (young OR younger)." The resulting study titles and abstracts were reviewed according to the eligibility criteria. Full articles were procured and reviewed for eligible studies, and their references were manually screened in an effort to identify additional studies that may have been missed. The tables of contents of the past 5y e a r so ft h eJournal of Shoulder and Elbow Surgery,t h e Journal of Bone and Joint Surgery, Clinical Orthopaedics and Related Research,andtheAmerican Journal of Sports Medicine were also reviewed. A PRISMA trial flow shows the study selection algorithm (Fig 1) .
Data Abstraction
Extracted data included study and patient characteristics, surgical technique, outcome scores, pain relief, satisfaction, functional improvement, return to activity, health-related quality of life, complications, need for and time to revision, range of motion, and radiological outcomes. Patients were stratified into the following treatment groups: HA, TSA, and AD. HA þ BR was excluded from the quantitative analysis because it is not well accepted in current practice and has shown great heterogeneity in clinical outcomes. 10, 16 R & R was also excluded from the analysis because published studies using this technique have been based on a single patient cohort. 15, [18] [19] [20] 
Data Items
Outcome scores of interest were the American Shoulder and Elbow Surgeons (ASES) 21 32, 33 and the EuroQol score. 34 Range of motion parameters included active forward flexion (FF), active abduction, active external rotation (ER) in the adducted position, and active internal rotation. Radiological outcomes included joint space, radiolucent lines, implant loosening or malalignment, subluxation, periprosthetic lucency, glenoid erosion, humeral head migration, glenoid erosion, and glenoid morphologic characteristics.
Data Synthesis
Data were aggregated when an outcome was homogeneously reported by at least 3 studies per treatment group. Continuous data were analyzed through computation of the mean and standard deviation, which were frequency weighted for the sample size. Data normality was assessed using the Shapiro-Wilk goodness of fit test. Statistical comparisons were conducted with the Kruskal-Wallis nonparametric test with the Tukey post hoc test for analyses of 3 or more groups or with the Wilcoxon nonparametric test for analyses of 2 groups. Dichotomous data were analyzed using the Pearson c-square test. Statistical significance was defined by P < .05. All statistical analyses were performed with JMP Pro, version 11.0 (SAS Institute, Cary, NC). All remaining extracted data were reviewed in descriptive fashion. The methodological quality of the studies was analyzed using the Modified Coleman Methodology Score, 35 ,36 a validated 15-item index with a scale of 0 to 100.
Results
Literature Search
The search of PubMed and Scopus identified 690 studies whose titles and abstracts were preliminarily screened. Full-text manuscripts for 73 studies were procured and reviewed. After application of the eligibility criteria, 32 studies published from 1995 to 2014 remained and were included in the systematic review (Table 1) 10,12-17,31,37-60 ; 18 of these studies using HA, TSA, or AD were included in the quantitative synthesis. The mean follow-up interval ranged from 26.7 to 119.7 months across treatment groups. The follow-up rate was between 24.1% and 100% in all studies. The mean Modified Coleman Methodology Score was 34.4 (range, 17 to 53).
Patient Characteristics
The mean age ranged from 43.6 to 47.9 years (male sex, 36.2% to 72.6%) across treatment groups ( Table 2 ). The dominant or right arm was involved in 56.5% to 70.3% of patients. Previous surgery had been performed in 36.2% to 56.0% of patients. The cause of the arthritis was primary osteoarthritis (n ¼ 456), shoulder instability or trauma (n ¼ 150), previous capsulorrhaphy or other shoulder surgery (i.e., chondrolysis) (n ¼ 143), an inflammatory condition (n ¼ 98), avascular necrosis (n ¼ 70), previous fracture (n ¼ 46), idiopathic cause (n ¼ 25), previous septic arthritis (n ¼ 4), glenoid dysplasia (n ¼ 2), or other (n ¼ 21). Staging of arthritis was infrequently reported and was conducted using multiple heterogeneous staging systems. There were some differences in patient demographics and preoperative clinical characteristics across treatment groups, including the follow-up interval, age, sex distribution, proportion of dominant or right arms, and preoperative active FF ( Table 3) .
Surgical Technique
Patients were treated with HA (n ¼ 459), TSA in 16 of 32 studies (Appendix Table 1 , available at www.arthroscopyjournal.org). 14, 16, 17, 31, 37, 38, [45] [46] [47] [50] [51] [52] Studies that used HA or TSA variably used anatomic versus resurfacing prostheses, cemented versus uncemented prostheses, and metal-backed versus polyethylene components. AD consisted of chondral debridement with or without associated procedures such as capsular release, subacromial decompression, loose body removal, and biceps tenodesis.
Subjective Outcomes
Seventeen studies reported VAS pain scores, 10, 14, 16, 17, 37, 39, 41, 42, [44] [45] [46] 49, 51, 53, 54, 57, 59 4 reported Constant pain scores, 47, 48, 55, 56 one reported ASES pain scores, 43 and one reported Neer and Cofield pain scores 31 (Appendix Tables 2 and 3 , available at www. arthroscopyjournal.org). Improvement in pain status, using an aggregate of standardized pain scores, was significantly greater after TSA than after HA (P < .001). Thirteen studies evaluated patient satisfaction, 10, 12, 14, 37, 38, 40, 42, 43, 45, 48, 49, 52, 55 which was similar after HA and TSA (P ¼ .5273).
Complications
The overall complication rate was reported or calculable in 20 studies. 10, [12] [13] [14] 16, 31, [37] [38] [39] 42, [46] [47] [48] [50] [51] [52] [53] [54] [55] [56] There were significantly fewer complications after AD than after HA (P ¼ .0049) and TSA (P < .001). Fewer complications also occurred after HA than after TSA (P ¼ .0042). Twenty-eight studies reported the proportion of patients requiring revision surgery, 10, 14, 16, 17, [37] [38] [39] [40] [41] [43] [44] [45] [46] [48] [49] [50] [51] [53] [54] [55] [56] [57] 59, 61 which was similar across treatment groups (P ¼ .9023).
Range of Motion
Twenty-two studies reported the range of active FF (Appendix Table 4 , available at www. arthroscopyjournal.org). 10, 13, 14, 17, 38, [41] [42] [43] [44] [45] [46] 48, 49, [51] [52] [53] [54] [55] [57] [58] [59] [60] Final FF was significantly higher after AD (P < .001) and significantly lower after HA (P < .001) than after all other treatments. The improvement in FF was greater after TSA than after AD (P < .001) and greater after AD than after HA (P ¼ .0107). Ten studies reported the range of active ER in the adducted position. 10, 13, 14, 17, 31, 38, 39, [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] 55 The final ER was significantly higher after AD than after TSA (P < .001). 
Radiological Outcomes
The rate of subluxation, which was reported by 8 studies, 14, 31, 38, 42, 43, 47, 50, 53 was the only radiological outcome for which data could be pooled in multiple groups (Appendix Table 5 , available at www. arthroscopyjournal.org). Subluxation was similarly common after HA and TSA (P ¼ .1676).
Discussion
The impetus for this systemic review was the lack of consensus on the optimal management of glenohumeral arthritis in younger patients with higher activity levels. AD, HA þ BR, and R & R are alternative surgical treatments that have been proposed in this patient demographic instead of the traditional options of TSA and HA. Therefore, the goal of this review was to compare clinical and radiological outcomes across surgical treatment options in the setting of glenohumeral arthritis in the young patient younger than 60 years of age. Level IV data from 32 studies, containing 1,229 shoulders in total, were included in this systematic review and meta-analysis to address this question.
The findings of this review suggest that TSA and AD provide better clinical outcomes than does HA in the surgical treatment of glenohumeral arthritis in young patients. AD is clinically efficacious in the short term while avoiding short-term complications and longterm prosthetic wear, loosening, and bone loss associated with arthroplasty. In particular, TSA provided significantly greater mean improvement in standardized pain scores than did HA. Patients were likely to be satisfied equally after undergoing HA or TSA. Complications were significantly less common after AD than after HA and TSA, although the rate of revision surgery was between 18% and 20% after all 3 procedures. AD and TSA afforded better recovery of active FF and ER than did HA. At radiological followup, subluxation was observed at a similar rate after HA and TSA.
HA and TSA are the most common surgical treatment strategies for degenerative disease of the glenohumeral joint in the general population. 11 Advantages of HA over TSA include reduced operative time, 31 blood loss, 31 and technical difficulty. 11 There are concerns about long-term clinical outcomes with HA 58 because of glenoid erosion, subchondral sclerosis, and loss of joint space, all of which may potentially necessitate later conversion to TSA. [61] [62] [63] [64] Because conversion of humeral head replacement to TSA appears to provide suboptimal outcomes in comparison with initial primary TSA, 65,66 an important consideration in surgical planning is the feasibility of eventual conversion to another technique. Although AD may not alter the progression of degenerative disease, it may be a worthy alternative strategy because of its potential to alleviate symptoms, improve function, and delay arthroplasty while causing minimal surgical morbidity, 17, 67 as substantiated by its 0% complication rate in this review.
Limitations
There are limitations to this systematic review, including the quality of the evidence on which it is based. Because all included studies were of Level IV evidence, the likelihood of methodological bias was increased. The majority of studies contained one or more demonstrable biases, including selection, detection, attrition biases, or a combination. The methodological quality of these Level IV studies was poor according to the validated Modified Coleman Methodology Score. Although a mean age younger than 60 years was required for study inclusion in this review, a minority of elderly patients was likely included. As a result of limited or nonuniformly reported data, it was not possible to analyze certain outcomes for every treatment group. Our requirement of 3 studies per treatment group for pooling of an outcome limited the number of comparisons that were possible but theoretically decreased bias. The analyses yielded discordant findings in some cases for change from baseline versus postoperative values, which complicates interpretation. It has been previously noted that patients undergoing TSA may have particularly poor preoperative scores, making it easier to show statistically significant improvements from baseline. 11 This issue is difficult to avoid when using lower level evidence, in which preoperative parameters may be highly variable, rather than prospective controlled trials. However, our analysis of preoperative values, when amenable to pooling, allows contextualization of these findings. It was not possible to compare pooled outcome scores across treatment groups because no single outcome score was reported by 3 or more studies in the TSA and AD groups. The inconsistent use of several scoring systems is a limitation of the existing literature. Significant clinical heterogeneity was present within and across studies, including the disease process, coexisting pathologic conditions, previous surgery, concomitant procedures, implant type if applicable, and postoperative management. Importantly, the significant variation in the mean follow-up interval across the treatment groups must be taken into account when interpreting the findings of this review, particularly when considering that the long-term clinical benefit of AD has yet to be established. Indeed, the mean follow-up interval was 108 months and 120 months for patients treated with HA and TSA, respectively, versus 27 months for those who underwent AD. It is possible that arthroscopically treated patients had lesser stages of arthritis, but this information was infrequently and nonuniformly reported by the studies. HA þ BR was excluded from the pooled analyses because of excessive variability in its clinical outcomes, including high failure rates in recent reports, 16, 59 leading to its increasing disuse at some institutions. R & R was also not amenable to quantitative analysis because studies using this technique have analyzed a single patient cohort. 15, [18] [19] [20] Type II error is possible for those comparisons in which no significant difference was found, but given that most comparisons yielded significant differences, our study is adequately powered. Finally, it should be noted that biologic treatment options were not included in this study.
Conclusions
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